Form 4: Guardant Health Executive Chris Freeman Reports Stock Transactions
SEC Form 4
Chris Freeman, Chief Commercial Officer of Guardant Health, reports the vesting and disposal of restricted stock units to cover tax obligations.
Summary
- Chris Freeman, the Chief Commercial Officer of Guardant Health, Inc., filed a Form 4 detailing changes in beneficial ownership.
- On April 1, 2025, Freeman vested 1,928 and 1,667 shares of common stock from restricted stock units.
- The vesting of these restricted stock units occurred under awards granted on November 7, 2022, and December 13, 2023, respectively, with vesting schedules over three and four years.
- 1,106 shares were withheld by the company to cover tax obligations related to the vesting of the restricted stock units at a price of $42.47.
- Following these transactions, Freeman directly owns 42,292 shares of common stock and 10,004 and 11,571 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, common in publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax-related disposals.
Key Dates
| Date | Description |
|---|---|
| November 7, 2022 | Date of restricted stock unit award that vests over a four-year period. |
| December 13, 2023 | Date of restricted stock unit award that vests over a three-year period. |
| October 1, 2023 | 25% of the shares subject to the November 7, 2022 award vested. |
| October 1, 2024 | 33% of the shares subject to the December 13, 2023 award vested. |
| April 1, 2025 | Date of reported transactions: vesting of restricted stock units and disposal of shares for tax obligations. |
| April 2, 2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Guardant Health, Chris Freeman, Stock Options, Restricted Stock Units, Beneficial Ownership, Officer Transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.